Invention Grant
US08378098B2 Imidazol[1,2-α]quinoxalines and derivatives for the treatment of cancers
失效
咪唑啉[1,2-α]喹喔啉及其衍生物治疗癌症
- Patent Title: Imidazol[1,2-α]quinoxalines and derivatives for the treatment of cancers
- Patent Title (中): 咪唑啉[1,2-α]喹喔啉及其衍生物治疗癌症
-
Application No.: US12681201Application Date: 2008-10-03
-
Publication No.: US08378098B2Publication Date: 2013-02-19
- Inventor: Carine Deleuze-Masquefa , Georges Moarbess , Pierre-Antoine Bonnet , Frédéric Pinguet , Ali Bazarbachi , Françoise Bressolle
- Applicant: Carine Deleuze-Masquefa , Georges Moarbess , Pierre-Antoine Bonnet , Frédéric Pinguet , Ali Bazarbachi , Françoise Bressolle
- Applicant Address: FR Montpellier LB Beirut FR Montpellier
- Assignee: Universite de Montpellier I,American University of Beirut,Centre Regional de Lutte Contre le Cancer de Montpellier
- Current Assignee: Universite de Montpellier I,American University of Beirut,Centre Regional de Lutte Contre le Cancer de Montpellier
- Current Assignee Address: FR Montpellier LB Beirut FR Montpellier
- Agency: Baker Donelson Bearman Caldwell & Berkowitz, PC
- Priority: FR07/06928 20071003
- International Application: PCT/EP2008/063290 WO 20081003
- International Announcement: WO2009/043934 WO 20090409
- Main IPC: C07D471/00
- IPC: C07D471/00
![Imidazol[1,2-α]quinoxalines and derivatives for the treatment of cancers](/abs-image/US/2013/02/19/US08378098B2/abs.jpg.150x150.jpg)
Abstract:
Imidazo[1,2-a]quinoxaline compounds for the treatment of cancers as well as pharmaceutical compositions that include these compounds and their uses in therapy.The compound of general formula (I):
Public/Granted literature
- US20100249142A1 IMIDAZOL[1,2-alpha]QUINOXALINES AND DERIVATIVES FOR THE TREATMENT OF CANCERS Public/Granted day:2010-09-30
Information query